| Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies AG Renehan, M Tyson, M Egger, RF Heller, M Zwahlen The lancet 371 (9612), 569-578, 2008 | 6386 | 2008 |
| Body fatness and cancer—viewpoint of the IARC Working Group B Lauby-Secretan, C Scoccianti, D Loomis, Y Grosse, F Bianchini, K Straif New England journal of medicine 375 (8), 794-798, 2016 | 2912 | 2016 |
| Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis AG Renehan, M Zwahlen, C Minder, S T O'Dwyer, SM Shalet, M Egger The Lancet 363 (9418), 1346-1353, 2004 | 2094 | 2004 |
| Global burden of cancer attributable to high body-mass index in 2012: a population-based study M Arnold, N Pandeya, G Byrnes, AG Renehan, GA Stevens, M Ezzati, ... The lancet oncology 16 (1), 36-46, 2015 | 1054 | 2015 |
| Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre … MJM van der Valk, DE Hilling, E Bastiaannet, EMK Kranenbarg, GL Beets, ... The Lancet 391 (10139), 2537-2545, 2018 | 873 | 2018 |
| Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials AG Renehan, M Egger, MP Saunders, S T O'Dwyer Bmj 324 (7341), 813, 2002 | 854 | 2002 |
| Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis AG Renehan, L Malcomson, R Emsley, S Gollins, A Maw, AS Myint, ... The Lancet Oncology 17 (2), 174-183, 2016 | 760 | 2016 |
| Biological mechanisms linking obesity and cancer risk: new perspectives DL Roberts, C Dive, AG Renehan Annual review of medicine 61, 301-316, 2010 | 744 | 2010 |
| Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory M Arnold, HE Karim-Kos, JW Coebergh, G Byrnes, A Antilla, J Ferlay, ... European journal of cancer 51 (9), 1164-1187, 2015 | 700 | 2015 |
| Adiposity and cancer risk: new mechanistic insights from epidemiology AG Renehan, M Zwahlen, M Egger Nature Reviews Cancer 15 (8), 484-498, 2015 | 606 | 2015 |
| Obesity and cancer risk: the role of the insulin–IGF axis AG Renehan, J Frystyk, A Flyvbjerg Trends in Endocrinology & Metabolism 17 (8), 328-336, 2006 | 581 | 2006 |
| What is apoptosis, and why is it important? Education and debate AG Renehan, C Booth, CS Potten Bmj 322 (7301), 1536-1538, 2001 | 554 | 2001 |
| The obesity paradox in cancer: a review H Lennon, M Sperrin, E Badrick, AG Renehan Current oncology reports 18, 1-8, 2016 | 513 | 2016 |
| Obesity and cancer: pathophysiological and biological mechanisms AG Renehan, DL Roberts, C Dive Archives of physiology and biochemistry 114 (1), 71-83, 2008 | 511 | 2008 |
| Body composition and outcome in patients undergoing resection of colorectal liver metastases MG Van Vledder, S Levolger, N Ayez, C Verhoef, TCK Tran, ... Journal of British Surgery 99 (4), 550-557, 2012 | 486 | 2012 |
| Stem cells: the intestinal stem cell as a paradigm SP Bach, AG Renehan, CS Potten Carcinogenesis 21 (3), 469-476, 2000 | 482 | 2000 |
| Growth hormone, the insulin-like growth factor axis, insulin and cancer risk PE Clayton, I Banerjee, PG Murray, AG Renehan Nature Reviews Endocrinology 7 (1), 11-24, 2011 | 424 | 2011 |
| Incident cancer burden attributable to excess body mass index in 30 European countries AG Renehan, I Soerjomataram, M Tyson, M Egger, M Zwahlen, ... International journal of cancer 126 (3), 692-702, 2010 | 350 | 2010 |
| COSMOS-E: guidance on conducting systematic reviews and meta-analyses of observational studies of etiology OM Dekkers, JP Vandenbroucke, M Cevallos, AG Renehan, DG Altman, ... PLoS medicine 16 (2), e1002742, 2019 | 344 | 2019 |
| Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis EJ Crosbie, M Zwahlen, HC Kitchener, M Egger, AG Renehan Cancer Epidemiology, Biomarkers & Prevention 19 (12), 3119-3130, 2010 | 330 | 2010 |
